Mod GRF (Modified Growth Hormone-Releasing Factor), also known as CJC-1295 without DAC (Drug Affinity Complex), is a synthetic peptide analog of the endogenous growth hormone-releasing hormone (GHRH)
Nicotinamide works in a different way, as it prevents the transfer of melanosomes, which are the dark pigments, from the bottom of the skin to the top of the skin, which is the keratinocytes, in turn, preventing increased pigmentation
More frequent reporting of adverse effects (AEs) in real-world cohorts than those reported in initial clinical trials Reference Thirot, Briquet and Frippiat3 leads to prescriber hesitancy, unnecessary avoidance of appropriate therapy, and adverse impacts on antimicrobial stewardship efforts
Not an underlying health issue
Successful treatment of binge eating disorder with the GLP-1 agonist semaglutide: a retrospective cohort study